Dacogen News
Most Popular Dacogen Story
Astex hammered after regulators diss Dacogen application
Shares of Astex Pharmaceuticals ($ASTX) got hammered yesterday after regulators turned a skeptical eye on Eisai's request for an expanded use of Dacogen, a leukemia-related drug the biotech licensed Read more...
Latest Headlines
- February 10, 2012
- February 8, 2012
- December 13, 2006
- August 9, 2006
- July 19, 2006
- July 5, 2006
- May 2, 2006
- November 14, 2005
- October 26, 2005
- September 1, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
